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Abstract
Background: Severe hypoglycemia occurs in 6% of type 2
DM patients with a 6 to 7% mortality rate. Amidst the COVID-19
pandemic, there has been a higher rate of fatality among diabetes
patients, at least 22% of COVID-19 deaths in Wuhan, China.
Furthermore, the condition impairs physiological defense against
recurrent hypoglycemia in the future. Accordingly, the innovation
in this study aims to prevent severe hypoglycemia among type 2
patients through early risk screening, the use of preventative pro-
tocols, and patient and family empowerment. This intervention
bundle is called Hypoglycemia-Nursing Early Warning Score
System (Hy-NEWSS). 
Design and Methods: The innovation was implemented in
inpatient and outpatient settings, within two weeks with the fol-
lowing sequence: i) internal training, ii) Hy-NEWSS implementa-
tion, iii) outcomes evaluation. 
Results: Of the twenty-eight patients involved in the study, 3
patients (19%) had a high risk of hypoglycemia, while the remain-
ing had a low risk for the condition. However, at the end of the
study there was no event of severe hypoglycemia (0%), and only
1 event (6.33%) of mild hypoglycemia. The results also showed
that the accuracy of nurses in implementing the protocols was
93% and that during the evaluation, 95.62% of the responses of
the nurses from the inpatient and outpatient settings were positive.
Finally, the scores of the sensitivity and specificity evaluation
were 99% and 88%, respectively. 
Conclusion: It may be concluded from this initial study that
Hy-NEWSS is effective in preventing severe hypoglycemia, accu-
rate in identifying patient risk level for the condition, and has high
applicability to be implemented in hospital settings. 
Introduction
Severe hypoglycemia (SH) is estimated to occur in 6% of
patients with type 2 DM and has a mortality rate of 6% to 7%.1
Furthermore, its incidence increases the likelihood for patients to
experience hypoglycemia associated autonomic failure
(HAAF).2,3 During the COVID-19 pandemic, there has been a
higher rate of fatality among diabetes patients.4 Hypoglycemia is
one of the most common complications of diabetes, especially in
those undertaking insulin therapy.5,6 A study in Wuhan, China
revealed that at least 22% of COVID-19 deaths are related to the
disease.7 Based on the 4 months of clinical observation in one of
the type A hospitals in Jakarta, Indonesia, it was concluded that
hypoglycemia is one of the common cause of hospitalization of
type 2 DM (T2DM) patients, along with diabetic ketoacidosis
(DKA), hyperosmolar hyperglycemic syndrome (HHS), and
recurrent ulceration. However, SH was chosen as the central issue
because there was a period when it occurred 4 times during 1 cer-
tain month of observation. Thus, there was an average of 1 inci-
dence per week. Following the above findings, an internal discus-
sion was conducted involving the nurse managers, the nurse in
charge, and the nursing staffs to further analyze the local circum-
stances using the strengths, weaknesses, opportunities, and threats
(SWOT) method. The analysis result showed that SH was one of
the most important issues in T2DM patient care. It also showed
that the hospital had sufficient resources to overcome the SH prob-
lem. Therefore, a clinical innovation through protocol develop-
ment needs to be established to tackle the occurrence of this prob-
lem, especially in inpatient settings. 
As a basis for the protocol development, a task force was
appointed to collect and analyze recent publications, guidelines,
and evidence on SH prevention. After several weeks of literature
exploration, the team was unable to find any particular guideline
on SH prevention in hospital settings from several online scientif-
ic databases. Therefore, a certain protocol needs to be developed
as a preventative measure for SH in hospital settings. 
Based on the situation above, this project was then named
hypoglycemia-nursing early warning score system (Hy-NEWSS).
Meanwhile, this is an early warning system that would comple-
ment the pre-existing general nursing early warning system. In the
initial stage, the Hy-NEWSS project had the following objectives:
i) to develop, apply, and evaluate the SH risk screening tool, ii) to
develop, apply, and evaluate intervention protocols to prevent the
occurrence of SH.
Significance for public health
Hypoglycemia is a deteriorating problem and affects type 2 diabetes patients in both hospital and community settings. Furthermore, its incidence was reported
to be significantly higher in patients undertaking insulin therapy, especially those suffering from other chronic comorbidities. Currently, there is no standard-
ized prevention protocol for hypoglycemia. Therefore, this study describes an initial effort in developing an evidence-based intervention bundle to prevent the
condition.
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This project was conducted in a multistage process, where dif-
ferent methods were used depending on the aim of each stage. The
breakdown of each stage and the corresponding methods is provid-
ed in Table 1. In general, there were three stages as follows:
1. Pre-clinical preparation
The objective of this stage is to develop a stratification tool for
classifying SH risk, and to develop a protocol to manage each
risk level. Such objectives were achieved through systematic
review of the current literature. 
2. Clinical study (pilot project)
In this stage, the objectives were:
-    To measure the sensitivity and specificity of the risk strati-
fication tool.
-    To measure the effectiveness of the SH prevention proto-
cols.
-    To obtain nurses’ perceptions about the clinical relevance of
the project.
These objectives were achieved using a quasi-experimental, with a
prospective cohort method. Participants were nurses in the
inpatient setting, internal medicine ward. 
3. Data analysis
This stage was aimed to analyze the data gathered from the
clinical trial, both from patients’ outcomes and the nurses’ perspec-
tives on the clinical visibility of the project. 
The study was conducted in one of the type A hospitals in
Jakarta, Indonesia. Moreover, this hospital is a referral hospital and
receives patients from lower types of hospitals. Thus, most of the
patients in this hospital have multiple comorbidities and significant
complications. With these conditions, patients are at risk of devel-
oping severe hypoglycemia. Participants were categorized into two
groups, patient-participants and nurse-participants. The patient
participants were adults with T2DM, while the nurse participants
were nurses working in the inpatient diabetes care unit. 
Results and Discussions
This study involved 20 nursing staff, and the intervention was
performed on 28 patients. Due to the outbreak of the covid-19 pan-
demic, the implementation period of this study was unexpectedly
reduced to only seven days. However, the 7 days of implementa-
tion was still able to provide some insights about the Hy-NEWSS
project. The patients were of equal proportion in terms of gender,
and each of them suffered from various T2DM complications
including retinopathy, foot ulceration, end-stage renal disease, and
peripheral neuropathy. 
The risk stratification tool
There were very limited numbers of SH risk stratification
tools. Also, the systematic review only found 2 articles addressing
this issue, the first one by Karter et al.,8 and the one developed by
Han et al.9 was selected as the most relevant to this project. One of
the main advantages of the tool used in this study is that it incor-
porates comorbid conditions as one of the determining factors of
SH risk. 
At the initial screening, 4 patients (14.29%) were identified as
having a high risk of SH, while the remaining 85.71% had a low
risk. The screening itself was conducted daily for each patient in
order to anticipate the dynamics and changes in the conditions of
each of them. Finally, the risk levels were subject to corresponding
preventive protocol. At the end of the intervention, it was ascer-
tained that the sensitivity of the risk stratification tool was 99%,
while the specificity was 88%. Furthermore, the positive and neg-
ative predictive values were 24 and 99%, respectively.  From the
nurses’ perspective, the use of hypoglycemia risk stratification tool
was perceived as a favorable intervention. As indicated in the Table
2, 100% of the respondents agreed or strongly agreed that it is clin-
ically beneficial for patients and need to be performed on a regular
basis. The availability of the stratification tool as a digital platform
was also found easy to use and does not increase nurse workload
as indicate by 75% and 70% of the respondents respectively. 
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Table 1. Breakdown of the study stages and methods.
Stage                                            Aim                                                                                                         Methods                              Timeframe 
Preclinical Preparation                          To develop a stratification tool for SH risk level                                                         Systematic review                        6 weeks
                                                                     To develop an intervention protocol for each risk level                                            Systematic review                        
Clinical study (pilot project)                 To measure the sensitivity and specificity of the risk stratification tool              Cohort study                                  4 weeks
                                                                     To measure the effectiveness of the SH prevention protocols                                                                                        
                                                                     To obtain nurses’ perceptions about the clinical relevance of the project         Cross-sectional study                 
Data analysis                                             To evaluate the results of the clinical study stage                                                     Statistical analysis                        1 week
SH, severe hypoglycemia. 
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Table 2. Nurse participants’ perceptions on SH risk stratification tool.
Evaluation item                                                                                           Strongly disagree      Disagree             Agree        Strongly agree
This SH risk stratification tool is:
        Clinically beneficial for patients                                                                                                        0                                   0                       16 (80%)                  4 (20%)
        Suitable for hospital use                                                                                                                1 (5%)                              0                       17 (85%)                  2 (10%)
        Needs to be performed on a regular basis                                                                                    0                                   0                       17 (85%)                  3 (15%)
        Does not increase nurses’ workloads                                                                                         1 (5%)                        5 (25%)                 13 (65%)                   1 (5%)
        Easy to perform                                                                                                                                1 (5%)                        4 (20%)                 12 (60%)                  3 (15%)
        A significant part of nursing documentation                                                                                   0                                   0                       12 (60%)                  8 (40%)
        In line with nurses’ clinical authority                                                                                               0                                   0                       15 (75%)                  5 (25%)
        Suitable to be included as a standard procedure for the care of T2DM patients                 0                                   0                       14 (70%)                  6 (30%)










The hypoglycemia prevention protocols
A particular intervention bundle was developed for each SH
risk level. Furthermore, as previously described, the levels were
categorized as high risk and low risk with the cut-off point being
6%. For each risk level, the preventive protocol includes an obser-
vation guideline, a particular procedure, and a multidisciplinary
team. The intervention bundles were extracted from a large num-
ber of references including the American Diabetes Association,10
the Indonesian Society of endocrinology,11 Seaquist et al.,12 Riddle
et al.,13 Evert et al.,14 and Yale et al.3
During the intervention period, none of the patients with a high
risk of SH experienced the condition, which means that the inci-
dence of SH was 0 (0%) event. Also, only 1 (3.5%) patient experi-
enced mild hypoglycemia. In addition to patients’ clinical parame-
ters, this study also evaluated the relevance of the intervention
bundle to the hospital setting and the nurses’ perspective on how
the Hy-NEWSS could improve the nursing practice. Among the
patient participants, 27 (93%) received the protocols appropriately,
while only 2 (7%) received them inappropriately. This indicated
that the nurses were able to apply the protocols appropriately, and
may indicate that the protocols were easy to apply. 
The hypoglycemia risk stratification tool received 92.5% of
favorable responses from the nurse participants, which means that
the tool was deemed as clinically relevant to be applied to patients
in the hospital setting. Similarly, the hypoglycemia prevention pro-
tocols received 98.12% of favorable responses, which also means
that it was highly relevant to be applied. Finally, from the overall
perspective, the Hy-NEWSS intervention bundle received 96.25%
of favorable responses. Tables 2, 3, and 4 illustrate how nurse par-
ticipants perceive the clinical relevance of each tool and the overall
project.
The first thing to highlight in this study was the zero incidence
of SH during the Hy-NEWSS implementation, even though there
were some patient participants with high risk for the condition.
This may indicate that the intervention bundle was both accurate
and effective in preventing SH. Every aspect of the Hy-NEWSS
was built using the latest evidence, incorporated multi-modality
interventions, and used a multidisciplinary approach, with a
patient-centered care paradigm. Patients and families were also
given certain roles during Hy-NEWSS implementation. This is
because as stated by the IDF (2012) in its global guideline, ideally
T2DM management involves a multidisciplinary team.15 In addi-
tion, patients and families have to be put at the center of the circle
to manage their conditions themselves with the assistance of the
healthcare team.16 Patient and family education were one of the
cornerstones in achieving diabetes control goals.17 This is because
a combination of adequate knowledge and patient empowerment
increases the likelihood of patients achieving diabetes control tar-
gets.18 In a large scale-referral hospital, limited manpower often
becomes a recurring problem, especially in developing countries.
This condition even became worse amidst the COVID-19 pandem-
ic because of the number of healthcare professionals that are used
in COVID-19 treatment units. Therefore, patient and family acti-
vation may help to partially solve the manpower issue and con-
tribute towards a better clinical outcome. In this project, patient
and family education sessions were conducted in a gradual and
stepwise fashion. Furthermore, patients and families were
equipped with a handbook that contained information needed to
perform their roles during the Hy-NEWSS implementation. 
As stated by LaManna et al., effective patient-centered dia-
betes education contributes significantly in preventing hypo-
glycemia, both during hospitalization and following hospital dis-
charge.19 This could be achieved through an effective skill acqui-
sition by patients and families on the detection of early signs of
hypoglycemia, the proper response to the condition, and the appro-
priate use of emergency medical services.20 By doing so, the task
of taking care of patients would be shared between healthcare pro-
fessionals and families, and thus, there would adequate monitoring
and care for T2DM patients with high or low risk of SH. This could
then cause a reduction in the rate of hypoglycemia-related morbid-
ity and mortality. At the end of the implementation stage, a visibil-
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Table 3. Nurses’ perceptions on SH prevention protocols.
Evaluation item                                                                                           Strongly disagree      Disagree             Agree        Strongly agree
This SH prevention protocols are:
       Clinically beneficial for patients                                                                                                         0                                   0                       15 (75%)                  5 (25%)
       Suitable for hospital use                                                                                                                      0                                   0                       15 (75%)                  5 (25%)
       Needs to be performed on a regular basis                                                                                     0                                   0                       16 (80%)                  4 (20%)
       Does not increase nurses’ workloads                                                                                               0                             2 (10%)                 14 (70%)                  4 (20%)
       Easy to perform                                                                                                                                      0                              1 (5%)                  15 (75%)                  4 (20%)
       A significant part of nursing documentation                                                                                   0                                   0                       15 (75%)                  5 (25%)
       In line with nurses’ clinical authority                                                                                               0                                   0                       15 (75%)                  5 (25%)
       Suitable to be included as a standard procedure for the care of T2DM patients                 0                                   0                       16 (80%)                  4 (20%)
SH, severe hypoglycemia; T2DM, type 2 diabetes mellitus.
Table 4. Nurses’ perceptions on the overall project.
Evaluation item                                                                                           Strongly disagree      Disagree             Agree        Strongly agree
This Hy-NEWSS intervention bundle is:
        Clinically beneficial for patients                                                                                                        0                                   0                       15 (75%)                  5 (25%)
        Suitable for hospital use                                                                                                                     0                                   0                       15 (75%)                  5 (25%)
        Suitable for a further process into formal regulation                                                                 0                                   0                       15 (75%)                  5 (25%)
        Does not increase nurses’ workloads                                                                                              0                             6 (30%)                 12 (60%)                  2 (10%)
        Improves professional nursing practice                                                                                          0                                   0                       14 (70%)                  6 (30%)
        In line with nurses’ clinical authority                                                                                               0                                   0                       14 (70%)                  6 (30%)
Hy-NEWSS, hypoglycemia-nursing early warning score system. 










ity study was conducted to examine whether the Hy-NEWSS was
considered as a clinically visible intervention or not. The parame-
ters that were looked at are nurses’ perceptions of several aspects
as follows: i) clinical benefit for patients, ii) impact on workload,
iii) relevance to hospital settings, iv) urgency/clinical importance,
and v) relevance to professional nursing practice.
It was quite surprising that during the COVID-19 pandemic the
Hy-NEWSS intervention bundle was considered a highly favor-
able task, as most of the nurse participants’ responses were either
on the “agree” or “strongly agree” score. 
The risk stratification tool’s accuracy
The analysis on specificity (Sp) and sensitivity (Sn) showed
high scores of 88% and 99% respectively. These numbers were
higher than those of the original study by Han et al.9 The high Sn
score indicated that the HY-NEWSS was very accurate in predict-
ing the likelihood of T2DM patients to experience hypoglycemia.
Meanwhile, the high Sp score indicated that Hy-NEWSS was very
accurate in distinguishing those with a low possibility for the con-
dition. Interesting findings were exhibited by the predictive values
of the tool. The positive predictive value (PPV) was relatively low
(25%) which means that only 25% of the predicted patients were
actually experiencing hypoglycemia. This may indicate the effec-
tiveness of the preventative protocols, as they reduced the occur-
rence of hypoglycemia by 75%.  On the other hand, the negative
predictive value (NPV) value was very high (99%) which means
that the prediction on the non-occurrence of hypoglycemia was
actually relevant in reality. Both of these scores correspond to sup-
port the clinical effectiveness of the protocols to prevent the inci-
dence of hypoglycemia. 
Implications for nursing practice and public health
The Hy-NEWSS was aimed at preventing the occurrence of
SH in patients with T2DM in hospital settings. This intervention
bundle is an important preventive measure and is highly relevant
in the context of nursing practice. As reflected in the nursing diag-
nosis taxonomy in domain 4 and diagnosis class metabolism, one
of the responses of patients towards T2DM is the exhibition of
unstable blood glucose level.21 Furthermore, in the nursing inter-
ventions classification, hypoglycemia is one of the nursing inter-
ventions as reflected by the intervention label of hypoglycemia
management, which consists of preventative interventions of
hypoglycemia.22 From the aforementioned explanation, the link-
age between Hy-NEWSS and the nursing process is clearly visible. 
From the human adaptation system perspective, as postulated
by Roy in the Roy Adaptation Model, the Hy-NEWSS is a repre-
sentation of nursing care, which aims to facilitate patients to gain
adaptive response towards T2DM and prevent maladaptive/inef-
fective responses.23 The Hy-NEWSS interventions bundle pro-
vides adaptation support on regulator and cognator subsystems.
The regulator and cognator are parts of the Roy’s adaptation model
which serve as effector of human system in response to external
stimuli.24 Meanwhile, family empowerment in Hy-NEWSS repre-
sents the adaptive facilitation on the interdependence mode. 
In the Hy-NEWSS intervention bundle, nurses were actively
involved in patient care and took part in a multidisciplinary team,
which also involved physicians and dieticians, because the proto-
cols were developed using a multidisciplinary team perspective.
Besides, the protocols were developed to fall in-line with the glob-
al diabetes plan of the International Diabetes Federation (IDF), in
which it is stated that a multidisciplinary-well coordinated health-
care team is essential to achieve clinical parameters. In that docu-
ment, the IDF also stated that the collaboration needs to also
involve the management and decision makers.25
As indicated in the table 4, the overall intervention bundle was
perceived as suitable for hospital use, clinically beneficial for
patients, improves professional nursing practice, and is recom-
mended for further process into formal regulation as it received
100% favorable response (agree or strongly agree) from the
respondents on those items. Furthermore, a majority of respon-
dents (70%) perceived the Hy-NEWSS does not increase nurse
workload, and 100% of respondents perceived the Hy-NEWSS is
in line with nurses’ clinical authority.
Finally, the Hy-NEWSS also contains clinical novelty and rep-
resent the role of clinical nurse specialists in patient care. As stated
by Han et al. and Karter et al., recently the hypoglycemia preven-
tion protocols are scattered and locally developed. However, none
has been identified as an evidence-based protocol, and clinically
tested to become a guideline or best practice. Similarly, the SH risk
stratification protocol is also difficult to find in the online research
databases.8,9
Conclusions
From this initial study, it may be concluded that the risk strat-
ification tool has been proven as both sensitive and specific for
determining the risk of SH occurring. Further, the SH prevention
protocols are effective in reducing the incidence of SH as indicated
by the predictive value scores.
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